Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription Articles published in Arch Bronconeumol Retrieve available abstracts of 73 articles: HTML format

Single Articles

June 2026
1. CALL S, Botana-Rial M, Cordovilla R, Galvez C, et al
   SEPAR-SECT Recommendations for Perioperative Invasive Mediastinal Staging of Non-small Cell Lung Cancer.
   Arch Bronconeumol. 2026 Jun 11:S0300-2896(26)00145.
   PubMed     Abstract available
   
   
   
2. CANDAL-PEDREIRA C, Ruano-Ravina A, Calvo de Juan V, Cobo M, et al
   Clinical Characteristics and Survival Outcomes in Patients With Small Cell Lung Cancer in Spain: An Analysis of the Thoracic Tumor Registry (2016-2025).
   Arch Bronconeumol. 2026 Jun 4:S0300-2896(26)00209.
   PubMed     Abstract available
   
   
   
3. GOROSPE-SARASUA L, van Zeller C, Gomez-de-la-Fuente E
   Incidental Diagnosis of SAPHO Syndrome During Lung Cancer Screening With Low-Dose Thoracic CT.
   Arch Bronconeumol. 2026 Jun 4:S0300-2896(26)00205.
   PubMed    
   
   
   
4. SONG Q, Shang S, Zhai Z, Ma S, et al
   Circulating Tumor DNA is Associated With Pathologic Response and Survival Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Neoadjuvant Immunotherapy: A Systematic Review and Meta-Analysis.
   Arch Bronconeumol. 2026 Jun 4:S0300-2896(26)00212.
   PubMed     Abstract available
   
   
   
5. PORCEL JM, Hidalgo I, Marques M, Parisi E, et al
   Pleural Fluid Outperforms Plasma for Detection of Clinically Relevant Mutations in Lung Cancer-Associated Malignant Pleural Effusion.
   Arch Bronconeumol. 2026 Jun 3:S0300-2896(26)00199.
   PubMed     Abstract available
   
   
   April 2026
6. MONCUSI A, Buron A, Lugon G, Macia F, et al
   Risk Perception and Intention to Quit Smoking Among High-Risk Participants Enrolled in a European Lung Cancer Screening Trial in Spain.
   Arch Bronconeumol. 2026 Apr 26:S0300-2896(26)00165.
   PubMed    
   
   
   
7. CABALLEROS LAM M, Pujols Leon PR, Inarrairaegui M, Ezponda A, et al
   Comparison of Lung Cancer Screening Programs in Liver Transplant Recipients and the General Population.
   Arch Bronconeumol. 2026 Apr 9:S0300-2896(26)00124.
   PubMed     Abstract available
   
   
   March 2026
8. DZIEDZIC R, Kanyion P, Kon B, Kruk M, et al
   Low-dose Computed Tomography Lung Cancer Screening Participants Show Improved 10-year Survival Compared With Matched Controls: A Case-Control Study.
   Arch Bronconeumol. 2026 Mar 26:S0300-2896(26)00115.
   PubMed     Abstract available
   
   
   
9. SANCHEZ-CUCO A, Suarez M, Santisteve S, Vila A, et al
   Screened vs. Non-Screened Lung Cancer: Real-World Evidence of a Stage Shift.
   Arch Bronconeumol. 2026 Mar 14:S0300-2896(26)00088.
   PubMed    
   
   
   February 2026
10. ZENG B, Huang X, Lai B
    Navigating Diagnostic and Therapeutic Challenges in Rare SMARCA4-deficient Lung Cancer: Achieving Partial Response Through Regimen Change.
    Arch Bronconeumol. 2026 Feb 27:S0300-2896(26)00083.
    PubMed    
    
    
    
11. GOROSPE-SARASUA L, Martin-Pinacho JJ, Arrieta P
    The Renewed Role of Interventional Thoracic Radiology in TNM-9 Staging of Left Upper Lobe Lung Cancer With Ipsilateral Mediastinal Involvement Inaccessible to Endobronchial Ultrasound.
    Arch Bronconeumol. 2026 Feb 15:S0300-2896(26)00073.
    PubMed    
    
    
    
12. PAPAVASSILIOU KA, Papavassiliou AG
    Proposal for a Hybrid Anatomical and Biological Staging System in Lung Cancer.
    Arch Bronconeumol. 2026 Feb 4:S0300-2896(26)00049.
    PubMed    
    
    
    January 2026
13. MOLINA R, Trape J, Garrido A, Salas E, et al
    Clinical Application of Expert Software Based on Six Tumour Biomarkers to Stratify the Risk of Lung Cancer in a Pulmonary Rapid Diagnosis Unit.
    Arch Bronconeumol. 2026 Jan 9:S0300-2896(26)00003.
    PubMed     Abstract available
    
    
    
14. MAZZONE PJ
    The Future of Lung Cancer Screening.
    Arch Bronconeumol. 2026 Jan 9:S0300-2896(26)00005.
    PubMed    
    
    
    November 2025
15. ORDONEZ GOMEZ P, Minana MD, Garcia-Ballesteros C, Signes-Costa J, et al
    Immune Gene Polymorphisms and Lung Cancer Risk in Chronic Obstructive Pulmonary Disease with Emphysema.
    Arch Bronconeumol. 2025 Nov 4:S0300-2896(25)00388.
    PubMed    
    
    
    October 2025
16. DE-TORRES JP, Wilson DO, Wisnivesky JP, Salvatore MM, et al
    Chronic Respiratory Diseases and Lung Cancer Risk.
    Arch Bronconeumol. 2025 Oct 25:S0300-2896(25)00383.
    PubMed     Abstract available
    
    
    
17. TORRES-CADAVID E, Candal-Pedreira C, Ruano-Ravina A, Kelsey K, et al
    Is the Effect of Occupation on Lung Cancer Modified by Tobacco Use and Residential Radon Exposure? Results of a Pooling Study.
    Arch Bronconeumol. 2025 Oct 16:S0300-2896(25)00375.
    PubMed    
    
    
    
18. PARDESSUS A, Chalela R, Sanchez-Font A
    Peripheral Lung Cancer Diagnosis with New-Generation Convex-Probe Endobronchial Ultrasound Bronchoscope: A Case Report.
    Arch Bronconeumol. 2025 Oct 11:S0300-2896(25)00357.
    PubMed    
    
    
    
19. PROVENCIO M, Counago F
    Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: A PRO/CON Debate.
    Arch Bronconeumol. 2025 Oct 4:S0300-2896(25)00347.
    PubMed    
    
    
    
20. ALONSO ROBLES AM, Vivancos Gallego MJ, Gorospe Sarasua L
    Incidental Finding of a Solitary Sternal Plasmacytoma Detected at Lung Cancer Screening With Low-dose CT in a Smoker With HIV Infection.
    Arch Bronconeumol. 2025 Oct 4:S0300-2896(25)00349.
    PubMed    
    
    
    April 2025
21. RUANO-RAVINA A, de Koning HJ
    Feasibility of Lung Cancer Screening in Europe: A Pro/con Debate.
    Arch Bronconeumol. 2025 Apr 2:S0300-2896(25)00120.
    PubMed    
    
    
    
22. DIAZ-GARCIA E, Alfaro E, Perez-Moreno P, Lopez-Fernandez C, et al
    Immune Checkpoint Biomarkers Galectin-9 and TIM-3 Predict Melanoma and Lung Cancer Mortality in Obstructive Sleep Apnoea.
    Arch Bronconeumol. 2025 Apr 2:S0300-2896(25)00116.
    PubMed     Abstract available
    
    
    March 2025
23. TRONCHETTI J, Roy P, Laroumagne S, Lovato JB, et al
    Role of Therapeutic Bronchoscopy in Malignant Central Airway Obstruction Due to Small Cell Lung Cancer: Results From the EpiGETIF Registry.
    Arch Bronconeumol. 2025 Mar 20:S0300-2896(25)00086.
    PubMed    
    
    
    
24. RAMI-PORTA R, Asamura H, Rusch VW
    Out With the Old, in With the New: What Changes in the 9th Edition of the TNM Classification for Lung Cancer?
    Arch Bronconeumol. 2025 Mar 11:S0300-2896(25)00078.
    PubMed    
    
    
    February 2025
25. CANDAL-PEDREIRA C, Ruano-Ravina A, Santiago-Perez MI, Almazan Ortega R, et al
    Estimate of the Eligible Population for Lung Cancer Screening in Galicia: An Analysis of Potential Scenarios.
    Arch Bronconeumol. 2025 Feb 22:S0300-2896(25)00067.
    PubMed    
    
    
    January 2025
26. GOMEZ-HERNANDEZ MT, Rivas C, Varela G, Jimenez M, et al
    Unplanned Reoperation After Anatomical Pulmonary Resection for Lung Cancer: Rate, Risk Factors, Early Outcomes and Long-term Prognostic Influence Within a Prospective Multicentre Database.
    Arch Bronconeumol. 2025 Jan 6:S0300-2896(25)00008.
    PubMed     Abstract available
    
    
    November 2024
27. MUNOZ-MOLINA GM, Fra-Fernandez S, Cabanero-Sanchez A, Rojas-Tula DG, et al
    Prognostic Value of Adding Blood and Lymphatic Vessel Invasion to the 8th Classification of TNM in Lung Cancer in Stages I and II.
    Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00444.
    PubMed     Abstract available
    
    
    
28. DE LUCA GR, Diciotti S, Mascalchi M
    The Pivotal Role of Baseline LDCT for Lung Cancer Screening in the Era of Artificial Intelligence.
    Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00439.
    PubMed     Abstract available
    
    
    
29. GONZALEZ-CASTRO S, Cadavid-Fernandez N, Gorospe Sarasua L
    Silicone-induced Lymphadenopathy Mimicking Metastatic Lung Cancer.
    Arch Bronconeumol. 2024 Nov 2:S0300-2896(24)00416.
    PubMed    
    
    
    
30. AGUINAGALDE B, Ferrer-Bonsoms JA, Lopez I, Lizarbe IA, et al
    Comparison of 5-Year Survival and Disease Recurrence After Trisegmentectomy or Left Upper Lobectomy: A Propensity Score Analysis of the National GEVATS Database.
    Arch Bronconeumol. 2024;60:705-713.
    PubMed     Abstract available
    
    
    October 2024
31. ZHAO S, Li B, Yu Z, Du J, et al
    Individual and Structural Factors Influencing Participation to Low-Dose Computed Tomography Screening in a Chinese Centralized Lung Cancer Screening Cohort.
    Arch Bronconeumol. 2024 Oct 9:S0300-2896(24)00370.
    PubMed    
    
    
    
32. GARCIA-DIAZ A, Moyano-Rodriguez MJ, Garrido-Navas MDC, de Miguel-Perez D, et al
    Resectable Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization.
    Arch Bronconeumol. 2024 Oct 4:S0300-2896(24)00360.
    PubMed     Abstract available
    
    
    
33. JIMENEZ-GOMEZ M, Alba-de-Caceres I, de-Granda-Orive JI
    Sometimes it's What it Doesn't Look Like: Atypical Dissemination of Lung Adenocarcinoma.
    Arch Bronconeumol. 2024;60:664-665.
    PubMed    
    
    
    August 2024
34. PAPAVASSILIOU KA, Gogou VA, Papavassiliou AG
    Harnessing Tumor Mechanobiology in NSCLC Treatment.
    Arch Bronconeumol. 2024;60:523-525.
    PubMed    
    
    
    July 2024
35. BAEZA S, Gil D, Rosell A
    Reply to "Radiomics and Clinical Data for the Diagnosis of Incidental Pulmonary Nodules and Lung Cancer Screening: Correspondence".
    Arch Bronconeumol. 2024 Jul 27:S0300-2896(24)00288.
    PubMed    
    
    
    
36. XIE M, Lin X, Bao X, Liang Y, et al
    Tertiary Lymphoid Structure in Tumor Microenvironment and Immunotherapy of Lung Cancer.
    Arch Bronconeumol. 2024 Jul 27:S0300-2896(24)00285.
    PubMed     Abstract available
    
    
    
37. ORIVE D, Echepare M, Bernasconi-Bisio F, Sanmamed MF, et al
    Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment.
    Arch Bronconeumol. 2024 Jul 17:S0300-2896(24)00269.
    PubMed     Abstract available
    
    
    
38. CANDAL-PEDREIRA C, Ruano-Ravina A, Calvo de Juan V, Cobo M, et al
    Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry.
    Arch Bronconeumol. 2024 Jul 15:S0300-2896(24)00268.
    PubMed     Abstract available
    
    
    
39. RAMISETTI SV, Patra T, Munirathnam V, Sainath JV, et al
    NRF2 Signaling Pathway in Chemo/Radio/Immuno-Therapy Resistance of Lung Cancer: Looking Beyond the Tip of the Iceberg.
    Arch Bronconeumol. 2024 Jul 15:S0300-2896(24)00267.
    PubMed     Abstract available
    
    
    
40. DAUNGSUPAWONG H, Wiwanitkit V
    Radiomics and Clinical Data for the Diagnosis of Incidental Pulmonary Nodules and Lung Cancer Screening: Correspondence.
    Arch Bronconeumol. 2024 Jul 8:S0300-2896(24)00239.
    PubMed    
    
    
    
41. HUANG S, Li F
    Progressive Metastatic Pulmonary Calcification: CT, MR and Bone Scintigraphy.
    Arch Bronconeumol. 2024;60:437-438.
    PubMed    
    
    
    June 2024
42. CASCON-HERNANDEZ J, Lopez-Garcia J, Saidi I
    Right Adrenal Metastasis of Lung Cancer Diagnosed via Endoscopic Ultrasound (EUS-B) by a Pulmonologist.
    Arch Bronconeumol. 2024 Jun 18:S0300-2896(24)00230.
    PubMed    
    
    
    May 2024
43. BAEZA S, Gil D, Sanchez C, Torres G, et al
    Radiomics and Clinical Data for the Diagnosis of Incidental Pulmonary Nodules and Lung Cancer Screening: Radiolung Integrative Predictive Model.
    Arch Bronconeumol. 2024 May 31:S0300-2896(24)00192.
    PubMed     Abstract available
    
    
    
44. GUERRA-TORT C, Lopez-Vizcaino E, Santiago-Perez MI, Rey-Brandariz J, et al
    Time Dependence Between Tobacco Consumption and Lung Cancer Mortality in Spain.
    Arch Bronconeumol. 2024 May 31:S0300-2896(24)00193.
    PubMed     Abstract available
    
    
    
45. MO Y, Qin Y, Shangguan J, Wei D, et al
    Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement.
    Arch Bronconeumol. 2024 May 31:S0300-2896(24)00189.
    PubMed     Abstract available
    
    
    
46. OZTURK ERGUR F, Ozturk A, Ozdag O, Tatci E, et al
    When to Consider Invasive Lymph Node Staging in Non-Small-Cell Lung Cancer? A Novel Scoring System Utilising Metabolic Parameters in 18F-FDG PET/CT.
    Arch Bronconeumol. 2024 May 28:S0300-2896(24)00184.
    PubMed     Abstract available
    
    
    
47. WANG K, Yi H, Wang Y, Jin D, et al
    Proteome-Wide Multicenter Mendelian Randomization Analysis to Identify Novel Therapeutic Targets for Lung Cancer.
    Arch Bronconeumol. 2024 May 16:S0300-2896(24)00168.
    PubMed     Abstract available
    
    
    
48. TZOUVELEKIS A, Tsiri P, Sampsonas F
    Challenges in the Management of Lung Cancer in ILD.
    Arch Bronconeumol. 2024 May 16:S0300-2896(24)00174.
    PubMed    
    
    
    
49. GONZALEZ J, Seijo LM, de-Torres JP, Benitez ID, et al
    Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP.
    Arch Bronconeumol. 2024 May 16:S0300-2896(24)00170.
    PubMed     Abstract available
    
    
    
50. ASHIQUE S, Mishra N, Garg A, Kumar N, et al
    A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis.
    Arch Bronconeumol. 2024 May 6:S0300-2896(24)00144.
    PubMed     Abstract available
    
    
    
51. FORCADA BARREDA C, Fuentes Gago MG, Gomez Hernandez MT
    Subconjunctival Emphysema After Videothoracoscopic Segmentectomy.
    Arch Bronconeumol. 2024 May 4:S0300-2896(24)00138.
    PubMed    
    
    
    
52. CARDENAL BD, Serra-Mitja P
    A Rare Pulmonary Metastasis of Uveal Melanoma Diagnosed Through Endobronchial Endosonography and Fine Needle Aspiration: A Case Report.
    Arch Bronconeumol. 2024;60:298-299.
    PubMed    
    
    
    April 2024
53. PORCEL JM, Pont M, Sorolla A
    CRISPR Technology in Lung Diseases: The Example of Lung Cancer and Cystic Fibrosis.
    Arch Bronconeumol. 2024 Apr 30:S0300-2896(24)00128.
    PubMed    
    
    
    March 2024
54. GOROSPE L, Gomez-Bermejo MA, Mirambeaux-Villalona RM
    Partial Anomalous Pulmonary Venous Return Incidentally Detected at Lung Cancer Screening With Low-dose Thoracic CT.
    Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00071.
    PubMed    
    
    
    February 2024
55. SARDELLA L, Merlo E, Casutt A
    Endobronchial High-Grade Non-Hodgkin B-Cell Lymphoma Mimicking Small Cell Lung Cancer.
    Arch Bronconeumol. 2024 Feb 24:S0300-2896(24)00052.
    PubMed    
    
    
    
56. ANDRES BLANCO AM, Terranova Rios M, Perez Rodriguez A
    Carcinosarcoma: A Rare Lung Tumor.
    Arch Bronconeumol. 2024;60:109.
    PubMed    
    
    
    
57. GARCIA PULIDO B, Fernandez Fernandez A
    Pulmonary Malt Lymphoma With Amyloidosis: An Uncommon Pulmonary Entity.
    Arch Bronconeumol. 2024;60:107-108.
    PubMed    
    
    
    
58. GARCIA-PRIETO F, Rodriguez Perojo A, Rio Ramirez MT
    Endobronchial Ultrasound: Detection of Lung Adenocarcinoma and Unmasking of Superior Vena Cava Thrombosis. An Exceptional Case.
    Arch Bronconeumol. 2024;60:113.
    PubMed    
    
    
    
59. MATOS I, do Bom-Sucesso M, Pinto D
    Large Inflammatory Myofibroblastic Tumor of the Lung in a Pediatric Patient.
    Arch Bronconeumol. 2024;60:103-104.
    PubMed    
    
    
    January 2024
60. DE-TORRES JP, Alcaide AB, Campo A, Zulueta JJ, et al
    Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00417.
    PubMed     Abstract available
    
    
    
61. BRIONES ALVARADO SI, Hernandez Hernandez T, Garcia Lopez JJ, Garcia Martos M, et al
    Placental Transmogrification of the Lung Associated With Pulmonary Carcinoma: Unusual Presentation of a Pulmonary Nodule.
    Arch Bronconeumol. 2024;60:46-47.
    PubMed    
    
    
    December 2023
62. CANDAL-PEDREIRA C, Ruano-Ravina A, Calvo de Juan V, Cobo M, et al
    Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.
    Arch Bronconeumol. 2023 Dec 18:S0300-2896(23)00407.
    PubMed     Abstract available
    
    
    
63. RECUERO DIAZ JL, Gatius Caldero S, Rosado Rodriguez J, Caamano Villaverde V, et al
    Impact of Pleural Lavage Cytology Positivity on Early Recurrence After Surgery for Non-Small Cell Lung Cancer.
    Arch Bronconeumol. 2023 Dec 18:S0300-2896(23)00402.
    PubMed     Abstract available
    
    
    
64. BRAVO MENDOZA MP, Estrada Mallarino N, Ordonez Lozano PA
    Intrapleural Foreign Body Simulating Lung Metastasis.
    Arch Bronconeumol. 2023;59:835.
    PubMed    
    
    
    
65. MORENA D, Lumbreras S, Rodriguez JM, Campos C, et al
    Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection.
    Arch Bronconeumol. 2023;59:797-804.
    PubMed     Abstract available
    
    
    November 2023
66. ESTEBAN V, Javaloyes J, Martinez-Lopez S, Sancho-Chust JN, et al
    Alveolar Macrophage Expression Differs According to Lung Cancer Subtype.
    Arch Bronconeumol. 2023 Nov 9:S0300-2896(23)00363.
    PubMed    
    
    
    
67. DE LA SOTA-MONTERO R, Corral-Blanco M, Aguado-Agudo M, Revuelta-Salgado F, et al
    Primary Tracheal Small Cell Carcinoma: A Diagnostic Challenge.
    Arch Bronconeumol. 2023;59:752-753.
    PubMed    
    
    
    
68. FORCADA C, Gomez-Hernandez MT, Fuentes MG, Rivas CE, et al
    Robotic-Assisted Thoracoscopic Anatomical Lung Resection Improves Cardiopulmonary Outcomes in Patients With Body Mass Index>/=25kg/m(2): A Propensity Score Matching Analysis.
    Arch Bronconeumol. 2023;59:779-781.
    PubMed    
    
    
    
69. MUDANNAYAKE R, Martinez G, Bello I, Gimenez-Mila M, et al
    Non-Intubated Thoracic Surgery: A Physiological Approach.
    Arch Bronconeumol. 2023;59:699-701.
    PubMed    
    
    
    October 2023
70. MUNOZ M, Pavon A
    Long-term Use of Angiotensin-converting Enzyme Inhibitors Increases Substance P Levels, Which is Involved in the Risk of Lung Cancer.
    Arch Bronconeumol. 2023 Oct 11:S0300-2896(23)00314.
    PubMed    
    
    
    
71. BENITEZ S, Delgado F, Hespanhol V, Boyeras I, et al
    First Ibero-American Summit on Lung Cancer Screening.
    Arch Bronconeumol. 2023 Oct 11:S0300-2896(23)00311.
    PubMed    
    
    
    
72. MORA PINILLA J, Garcia Garcia A, Matesanz Lopez C, Rio Ramirez MT, et al
    Intrapulmonary Schwannoma: A Case Report.
    Arch Bronconeumol. 2023;59:664-665.
    PubMed    
    
    
    September 2023
73. TARRES J, Diego C, Alberti-Casas C
    Mesothelioma: An Ongoing Problem.
    Arch Bronconeumol. 2023;59:603-604.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum